#ITI#Identification and functional analysis of membrane proteins gD, gE, gI, and pUS9 of infectious laryngotracheitis virus#FTI#
#IRE#Herpesvirus envelope proteins are of particular interest for development of attenuated live, marker, and subunit vaccines, as well as development of diagnostic tools. The unique short genome region of the chicken pathogen infectious laryngotracheitis virus (ILTV, Gallid herpesvirus 1) contains a cluster of six conserved alphaherpesvirus genes encoding membrane proteins, of which up to now only glycoproteins gG and gJ have been analyzed in detail. We have now prepared monospecific rabbit antisera against ILTV gD, gE, and gI, and the ILTV type II membrane protein pUS9, each of which showed specific immunofluorescence reactions, and detected proteins of approximately 65 and 70 kDa (gD), 62 kDa (gI), 75 kDa (gE), or 37 kDa (pUS9) in western blot analyses of infected chicken cells. The proteins gD, gI, and gE, but not pUS9, were identified as abundant virion proteins, and gE and gI were shown to be N-glycosylated. We also isolated gE-, gI-, and pUS9-deleted ILTV recombinants, whereas it was not possible to purify gD-negative ILTV to homogeneity, indicating that gD, like in other alphaherpesviruses, is essential for receptor binding and virus entry. The pUS9-deleted ILTV exhibited almost wild-type-like replication properties in cell culture. The gE- and gI-negative viruses showed significantly reduced plaque sizes, whereas virus titers were barely affected. Since homologous gene-deletion mutants of other alphaherpesviruses are in use as live vaccines, the generated ILTV recombinants might be also suitable for this application. Â© American Association of Avian Pathologists.#FRE#
#IPC#Engineered gene deletion mutants of ILTV; gD; gE; gI; Infectious laryngotracheitis virus (ILTV); US9 protein; Viral glycoproteins#FPC#
#IRF#Andreasen Jr. J.R., Glisson J.R., Goodwin M.A., Resurreccion R.S., Villegas P., Brown J., Studies of infectious laryngotracheitis vaccines: Immunity in layers, Avian Dis., 33, pp. 524-530, (1989); 
Andreasen Jr. J.R., Glisson J.R., Villegas P., Differentiation of vaccine strains and Georgia field isolates of infectious laryngotracheitis virus by their restriction endonuclease fragment patterns, Avian Dis., 34, pp. 646-656, (1990); 
Babic N., Klupp B., Brack A., Mettenleiter T.C., Ugolini G., Flamand A., Deletion of glycoprotein gE reduces the propagation of pseudorabies virus in the nervous system of mice after intranasal inoculation, Virology, 219, pp. 279-284, (1996); 
Brideau A.D., Banfield B.W., Enquist L.W., The Us9 gene product of pseudorabies virus, an alphaherpesvirus, is a phosphorylated, tailanchored type II membrane protein, J. Virol., 72, pp. 4560-4570, (1998); 
Brideau A.D., Card J.P., Enquist L.W., Role of pseudorabies virus Us9, a type II membrane protein, in infection of tissue culture cells and the rat nervous system, J. Virol., 74, pp. 834-845, (2000); 
Brittle E.E., Wang F., Lubinski J.M., Bunte R.M., Friedman H.M., A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine, J. Virol., 82, pp. 8431-8441, (2008); 
Chandra Y.G., Lee J., Kong B.W., Genome sequence comparison of two United States live attenuated vaccines of infectious laryngotracheitis virus (ILTV), Virus Genes, 44, pp. 470-474, (2012); 
Chowdhury S.I., Onderci M., Bhattacharjee P.S., Al-Mubarak A., Weiss M.L., Zhou Y., Bovine herpesvirus 5 (BHV-5) Us9 is essential for BHV-5 neuropathogenesis, J. Virol., 76, pp. 3839-3851, (2002); 
Cohen J.I., Nguyen H., Varicella-zoster virus glycoprotein i is essential for growth of virus in Vero cells, J. Virol., 71, pp. 6813-6920, (1997); 
Connolly S.A., Whitbeck J.J., Rux A.H., Krummenacher C., Hurk Den Littel-Van Drunen S.Van, Cohen G.H., Eisenberg R.J., Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC (nectin-1) with different affinities, Virology, 280, pp. 7-18, (2001); 
Davison A.J., Eberle R., Ehlers B., Hayward G.S., McGeoch D.J., Minson A.C., Pellett P.E., Roizman B., Studdert M.J., Thiry E., The order Herpesvirales, Arch. Virol., 154, pp. 171-177, (2009); 
Davison A.J., Herpesvirus systematics, Vet. Microbiol., 143, pp. 52-69, (2010); 
Davison S., Gingerich E., Casavant N.S., Eckroade R.J., Evaluation of the efficacy of a live fowlpox-vectored infectious laryngotracheitis/avian encephalomyelitis vaccine against ILT viral challenge, Avian Dis., 50, pp. 50-54, (2006); 
Devlin J.M., Browning G.F., Hartley C.A., Kirkpatrick N.C., Mahmoudian A., Noormohammadi A.H., Gilkerson J.R., Glycoprotein G is a virulence factor in infectious laryngotracheitis virus, J. Gen. Virol., 87, pp. 2839-2847, (2006); 
Devlin J.M., Browning G.F., Gilkerson J.R., A glycoprotein Iand glycoprotein E-deficient mutant of infectious laryngotracheitis virus exhibits impaired cell-to-cell spread in cultured cells, Arch. Virol., 151, pp. 1281-1289, (2006); 
Dingwell K.S., Brunetti C.R., Hendricks R.L., Tang Q., Tang M., Rainbow A.J., Johnson D.C., Herpessimplex virus glycoproteins e and i facilitate cell-to-cell spread in vivo and across junctions of cultured cells, J Virol., 68, pp. 834-845, (1994); 
Esko J.D., Bertozzi C.R., Chemical tools for inhibiting glycosylation, Essentials of Glycobiology, (2009); 
Fuchs W., Mettenleiter T.C., DNA sequence and transcriptional analysis of the UL1 to UL5 gene cluster of infectious laryngotracheitis virus, J. Gen. Virol., 77, pp. 2221-2229, (1996); 
Fuchs W., Ziemann K., Teifke J.P., Werner O., Mettenleiter T.C., The non-essential UL50 gene of avian infectious laryngotracheitis virus encodes a functional dUTPase which is not a virulence factor, J. Gen. Virol., 81, pp. 627-638, (2000); 
Fuchs W., Klupp B.G., Granzow H., Osterrieder N., Mettenleiter T.C., The interacting UL31 and UL34 gene products of pseudorabies virus are involved in egress from the host-cell nucleus and represent components of primary enveloped but not mature virions, J. Virol., 76, pp. 364-378, (2001); 
Fuchs W., Wiesner D., Veits J., Teifke J.P., Mettenleiter T.C., In vitro and in vivo relevance of infectious laryngotracheitis virus gJ proteins that are expressed from spliced and nonspliced mRNAs, J. Virol., 79, pp. 705-716, (2005); 
Fuchs W., Veits J., Helferich D., Granzow H., Teifke J.P., Mettenleiter T.C., Molecular biology of avian infectious laryngotracheitis virus, Vet. Res., 38, pp. 261-279, (2007); 
Geraghty R.J., Krummenacher C., Cohen G.H., Eisenberg R.J., Spear P.G., Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor, Science, 280, pp. 1618-1620, (1998); 
Guy J.S., Barnes H.J., Smith L.G., Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-tobird passage, Avian Dis., 35, pp. 348-355, (1991); 
Guy J.S., Garcia M., Laryngotracheitis, Diseases of Poultry, pp. 137-152, (2008); 
Helferich D., Veits J., Mettenleiter T.C., Fuchs W., Identification of transcripts and protein products of the UL31, UL37, UL46, UL47, UL48, UL49 and US4 gene homologues of avian infectious laryngotracheitis virus, J. Gen. Virol., 88, pp. 719-731, (2007); 
Helferich D., Veits J., Teifke J.P., Mettenleiter T.C., Fuchs W., The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens, J. Gen. Virol., 88, pp. 732-742, (2007); 
Kaashoek M.J., Van Engelenburg F.A., Moerman A., Gielkens A.L., Rijsewijk F.A., Van Oirschot J.T., Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants, Vet. Microbiol., 48, pp. 143-153, (1996); 
Kawaguchi T., Nomura K., Hirayama Y., Kitagawa T., Establishment and characterization of a chicken hepatocellular carcinoma cell line lmh, Cancer Res., 47, pp. 4460-4464, (1987); 
Kimman T.G., Pol J.M., De Wind N., Oei-Lie N., Berns A.J., Gielkens A.L., Role of different genes in the virulence and pathogenesis of Aujeszky's disease virus, Vet. Microbiol., 33, pp. 45-52, (1992); 
Kimman T.G., Gielkens A.L., Glazenburg K., Jacobs L., De Jong M.C., Mulder W.A., Peeters B.P., Characterization of live pseudorabies virus vaccines, Dev. Biol. Stand., 84, pp. 89-96, (1995); 
Kongsuwan K., Johnson M.A., Prideaux C.T., Sheppard M., Identification of an infectious laryngotracheitis virus gene encoding an immunogenic protein with a predicted Mr of 32 kilodaltons, Virus Res., 29, pp. 125-140, (1993); 
Kornfeld R., Kornfeld S., Assembly of asparagine-linked oligosaccharides, Annu. Rev. Biochem., 54, pp. 631-664, (1985); 
Kotiw M., Wilks C.R., May J.T., The effect of serial in vivo passage on the expression of virulence and DNA stability of an infectious laryngotracheitis virus strain of low virulence, Vet. Microbiol., 45, pp. 71-80, (1995); 
Kozak M., Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes, Cell, 44, pp. 283-292, (1986); 
Lee S.W., Markham P.F., Markham J.F., Petermann I., Noormohammadi A.H., Browning G.F., Ficorilli N.P., Hartley C.A., Devlin J.M., First complete genome sequence of infectious laryngotracheitis virus, BMC Genomics, 12, (2011); 
Lee S.W., Markham P.F., Coppo M.J., Legione A.R., Markham J.F., Noormohammadi A.H., Browning G.F., Ficorilli N., Hartley C.A., Devlin J.M., Attenuated vaccines can recombine to form virulent field viruses, Science, 337, (2012); 
Leege T., Fuchs W., Granzow H., Kopp M., Klupp B.G., Mettenleiter T.C., Effects of simultaneous deletion of pUL11 and glycoprotein M on virion maturation of herpes simplex virus type 1, J. Virol., 83, pp. 896-907, (2009); 
Leib D.A., Bradbury J.M., Hart C.A., McCarthy K., Genome isomerism in two alphaherpesviruses: Herpesvirus saimiri-1 (Herpesvirus tamarinus) and avian infectious laryngotracheitis virus, Arch. Virol., 93, pp. 287-294, (1987); 
Longnecker R., Roizman B., Clustering of genes dispensable for growth in culture in the S component of the HSV-1 genome, Science, 236, pp. 573-576, (1987); 
Mallory S., Sommer M., Arvin A.M., Analysis of the glycoproteins i and e of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids, J. Infect. Dis., 178, SUPPL. 1, (1998); 
McGeoch D.J., Dolan A., Ralph A.C., Toward a comprehensive phylogeny for mammalian and avian herpesviruses, J. Virol., 74, pp. 10401-10406, (2000); 
Mettenleiter T.C., Lukacs N., Rziha H.J., Pseudorabies virus avirulent strains fail to express a major glycoprotein, J. Virol., 56, pp. 307-311, (1985); 
Mettenleiter T.C., Glycoprotein gIII deletion mutants of pseudorabies virus are impaired in virus entry, Virology, 171, pp. 623-625, (1989); 
Pavlova S.P., Veits J., Keil G.M., Mettenleiter T.C., Fuchs W., Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase, Vaccine, 27, pp. 773-785, (2009); 
Pavlova S.P., Veits J., Blohm U., Maresch C., Mettenleiter T.C., Fuchs W., In vitro and in vivo characterization of glycoprotein Cdeleted infectious laryngotracheitis virus, J. Gen. Virol., 91, pp. 847-857, (2010); 
Petrovskis E.A., Timmins J.G., Armentrout M.A., Marchioli C.C., Yancey Jr. R.J., Post L.E., DNA sequence of the gene for pseudorabies virus gp50, a glycoprotein without N-linked glycosylation, J. Virol., 59, pp. 216-223, (1986); 
Rauh I., Mettenleiter T.C., Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration, J. Virol., 65, pp. 5348-5356, (1991); 
Rebordosa X., Pinol J., Perez-Pons J.A., Lloberas J., Naval J., Serra-Hartmann X., Espuna E., Querol E., Glycoprotein e of bovine herpesvirus type 1 is involved in virus transmission by direct cell-to-cell spread, Virus Res., 45, pp. 59-68, (1996); 
Roizman B., Knipe D.M., Whitney R.J., Herpes Simplex Viruses, pp. 2501-2601, (2007); 
Schnitzlein W.M., Winans R., Ellsworth S., Tripathy D.N., Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus, Virology, 209, pp. 304-314, (1995); 
Schumacher D., Tischer B.K., Reddy S.M., Osterrieder N., Glycoproteins e and i of Marek's disease virus serotype 1 are essential for virus growth in cultured cells, J. Virol., 75, pp. 11307-11318, (2001); 
Shil N.K., Markham P.F., Noormohammadi A.H., O'Rourke D., Devlin J.M., Development of an enzyme-linked immunosorbent assay to detect chicken serum antibody to glycoprotein G of infectious laryngotracheitis virus, Avian Dis., 56, pp. 509-515, (2012); 
Tan X., Brunovskis P., Velicer L.F., Transcriptional analysis of Marek's disease virus glycoprotein D, I, and e genes: GD expression is undetectable in cell culture, J. Virol., 75, pp. 2067-2075, (2001); 
Thureen D.R., Keeler Jr. C.L., Psittacid herpesvirus 1 and infectious laryngotracheitis virus: Comparative genome sequence analysis of two avian alphaherpesviruses, J. Virol., 80, pp. 7863-7872, (2006); 
Tong G.Z., Zhang S.J., Wang L., Qiu H.J., Wang Y.F., Wang M., Protection of chickens from infectious laryngotracheitis with a recombinant fowlpox virus expressing glycoprotein B of infectious laryngotracheitis virus, Avian Pathol., 30, pp. 143-148, (2001); 
Vagnozzi A., Zavala G., Riblet S.M., Mundt A., Garcia M., Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens, Avian Pathol., 41, pp. 21-31, (2012); 
Van Oirschot J.T., Diva vaccines that reduce virus transmission, J. Biotechnol., 73, pp. 195-205, (1999); 
Veits J., Kollner B., Teifke J.P., Granzow H., Mettenleiter T.C., Fuchs W., Isolation and characterization of monoclonal antibodies against structural proteins of infectious laryngotracheitis virus, Avian Dis., 47, pp. 330-342, (2003); 
Veits J., Luschow D., Kindermann K., Werner O., Teifke J.P., Mettenleiter T.C., Fuchs W., Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague, J. Gen. Virol., 84, pp. 3343-3352, (2003); 
Von Heijne G., A new method for predicting signal sequence cleavage sites, Nucleic Acids Res., 14, pp. 4683-4690, (1986); 
Whealy M.E., Card J.P., Robbins A.K., Dubin J.R., Rziha H.J., Enquist L.W., Specific pseudorabies virus infection of the rat visual system requires both gI and gp63 glycoproteins, J. Virol., 67, pp. 3786-3797, (1993); 
Whitbeck J.C., Knapp A.C., Enquist L.W., Lawrence W.C., Bello L.J., Syn thesis, processing, and oligomerization of bovine herpesvirus 1 gE and gI membrane proteins, J. Virol., 70, pp. 7878-7884, (1996); 
Wild M.A., Cook S., Cochran M., A genomic map of infectious laryngotracheitis virus and the sequence and organization of genes present in the unique short and flanking regions, Virus Genes, 12, pp. 107-116, (1996); 
Williams R.A., Bennett M., Bradbury J.M., Gaskell R.M., Jones R.C., Jordan F.T., Demonstration of sites of latency of infectious laryngotracheitis virus using the polymerase chain reaction, J. Gen. Virol., 73, pp. 2415-2420, (1992); 
Ziemann K., Mettenleiter T.C., Fuchs W., Gene arrangement within the unique long genome region of infectious laryngotracheitis virus is distinct from that of other alphaherpesviruses, J. Virol., 72, pp. 847-852, (1998); 
Ziemann K., Mettenleiter T.C., Fuchs W., Infectious laryngotracheitis herpesvirus expresses a related pair of unique nuclear proteins which are encoded by split genes located at the right end of the UL genome region, J. Virol., 72, pp. 6867-6874, (1998); 
Zuckermann F.A., Mettenleiter T.C., Schreurs C., Sugg N., Ben-Porat T., Complex between glycoproteins gI and gp63 of pseudorabies virus: Its effect on virus replication, J. Virol., 62, pp. 4622-4626, (1988)#FRF#
